| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3193061 | Annals of Allergy, Asthma & Immunology | 2008 | 8 Pages |
Abstract
Olopatadine, at 0.1% and 0.2% concentrations, was effective in suppressing allergen-induced nasal symptoms. At 0.2%, olopatadine provided evidence suggestive of inhibition of mast cell degranulation.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Patrik Pipkorn, Candy Costantini, Curt Reynolds, Michael Wall, Margaret Drake, Alvin Sanico, David Proud, Alkis MD,